Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Safety and Efficacy of Acnase Creme in Acne Vulgaris
NCT00877409Phase 3Unknown
- Start
- Apr 2009
- Primary completion
- Jul 2009
- Countries
- 1
01
Overview
Phase 3, randomised, single-blind trial in acne vulgaris comparing Acnase with Vehicle (2 arms). Primary endpoint: Average clinical development of target lesions at 12 weeks. Status: unknown.
02
Drugs
Acnase
03
Conditions
acne vulgaris
Beyond the preview
Go deeper on NCT00877409.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00877409.